Logo-apb
Adv Pharm Bull. 2019;9(3): 360-373. doi: 10.15171/apb.2019.043
PMID: 31592054        PMCID: PMC6773933

Review Article

The Potential of Magnetic Nanoparticles for Diagnosis and Treatment of Cancer Based on Body Magnetic Field and Organ-on-the-Chip

Ali Alirezaie Alavijeh 1 ORCID, Mohammad Barati 2 * ORCID, Meisam Barati 3 ORCID, Hussein Abbasi Dehkordi 1 ORCID

Cited by CrossRef: 25


1- Sharma K, Pathak A, Rawat A, chaubey J, Sharma A, tomar H, singh S. ‘‘Development approach and application of magnetic nanoparticles and encapsulation method’’. Materials Today: Proceedings. 2024;103:500 [Crossref]
2- Martín M, Gentili C, Lassalle V. In vitro Biological Tests as the First Tools To Validate Magnetic Nanotheranostics for Colorectal Cancer Models. ChemMedChem. 2020;15(12):1003 [Crossref]
3- Phan K, Ha P, Do H, Nguyen T, Bui T, Pham H, Le M, Le T. Dual Loading of Doxorubicin and Magnetic Iron Oxide into PLA‐TPGS Nanoparticles: Design, in vitro Drug Release Kinetics, and Biological Effects on Cancer Cells. ChemMedChem. 2021;16(23):3615 [Crossref]
4- Khizar S, Ben Halima H, Ahmad N, Zine N, Errachid A, Elaissari A. Magnetic nanoparticles in microfluidic and sensing: From transport to detection. Electrophoresis. 2020;41(13-14):1206 [Crossref]
5- Şen Ö, Emanet M, Ciofani G. Nanotechnology‐Based Strategies to Evaluate and Counteract Cancer Metastasis and Neoangiogenesis. Adv Healthcare Materials. 2021;10(10) [Crossref]
6- Shariati M. The cancer therapy materialization by theranostic nanoparticles based on gold doped iron oxide under electromagnetic field amplification. Nanomedicine: Nanotechnology, Biology and Medicine. 2021;35:102406 [Crossref]
7- Fatima Qizilbash F, Sartaj A, Qamar Z, Kumar S, Imran M, Mohammed Y, Ali J, Baboota S, Ali A. Nanotechnology revolutionises breast cancer treatment: harnessing lipid-based nanocarriers to combat cancer cells. Journal of Drug Targeting. 2023;31(8):794 [Crossref]
8- Khizar S, Ahmad N, Zine N, Jaffrezic-Renault N, Errachid-el-salhi A, Elaissari A. Magnetic Nanoparticles: From Synthesis to Theranostic Applications. ACS Appl Nano Mater. 2021;4(5):4284 [Crossref]
9- Cerqueira M, Belmonte-Reche E, Gallo J, Baltazar F, Bañobre-López M. Magnetic Solid Nanoparticles and Their Counterparts: Recent Advances towards Cancer Theranostics. Pharmaceutics. 2022;14(3):506 [Crossref]
10- Chauhan A, Midha S, Kumar R, Meena R, Singh P, Jha S, Kuanr B. Rapid tumor inhibitionviamagnetic hyperthermia regulated by caspase 3 with time-dependent clearance of iron oxide nanoparticles. Biomater Sci. 2021;9(8):2972 [Crossref]
11- Gimondi S, Ferreira H, Reis R, Neves N. Microfluidic Devices: A Tool for Nanoparticle Synthesis and Performance Evaluation. ACS Nano. 2023;17(15):14205 [Crossref]
12- Monahan D, Almas T, Wyile R, Cheema F, Duffy G, Hameed A. Towards the use of localised delivery strategies to counteract cancer therapy–induced cardiotoxicities. Drug Deliv and Transl Res. 2021;11(5):1924 [Crossref]
13- Martín M, Azcona P, Lassalle V, Gentili C. Doxorubicin delivery by magnetic nanotheranostics enhances the cell death in chemoresistant colorectal cancer-derived cells. European Journal of Pharmaceutical Sciences. 2021;158:105681 [Crossref]
14- Zimina T, Sitkov N, Gareev K, Mikhailova N, Combs S, Shevtsov M. Hybrid-integrated devices for mimicking malignant brain tumors (“tumor-on-a-chip”) for in vitro development of targeted drug delivery and personalized therapy approaches. Front Med. 2024;11 [Crossref]
15- Sun W, Chai X, Zhang Y, Yu T, Wang Y, Zhao W, Liu Y, Yin D, Zhang C. Combination Using Magnetic Iron Oxide Nanoparticles and Magnetic Field for Cancer Therapy. The Chemical Record. 2024; [Crossref]
16- Morey J, Llinás P, Bueno-Costa A, León A, Piña M. Raltitrexed-Modified Gold and Silver Nanoparticles for Targeted Cancer Therapy: Cytotoxicity Behavior In Vitro on A549 and HCT-116 Human Cancer Cells. Materials. 2021;14(3):534 [Crossref]
17- Shivanna A, Dash B, Lu Y, Lin W, Chen J. Magnetic lipid-poly(lactic-co-glycolic acid) nanoparticles conjugated with epidermal growth factor receptor antibody for dual-targeted delivery of CPT-11. International Journal of Pharmaceutics. 2024;667:124856 [Crossref]
18- Almatroudi A. Unlocking the Potential of Silver Nanoparticles: From Synthesis to Versatile Bio-Applications. Pharmaceutics. 2024;16(9):1232 [Crossref]
19- Lemmerman L, Das D, Higuita-Castro N, Mirmira R, Gallego-Perez D. Nanomedicine-Based Strategies for Diabetes: Diagnostics, Monitoring, and Treatment. Trends in Endocrinology & Metabolism. 2020;31(6):448 [Crossref]
20- Eivazzadeh-Keihan R, Gorab M, Aliabadi H, Noruzi E, Kashtiaray A, Bani M, Etminan A, Mirzahoseini H, Cohan R, Maleki A, Mahdavi M. Investigation of biological activity and hyperthermia application of a quaternary magnetic nanobiocomposite based on functionalized carbon nitride nanosheets by carboxymethyl cellulose hydrogel and silk fibroin. Cellulose. 2023;30(5):2997 [Crossref]
21- Sharma S, Kuppusamy G, Chowdhury P, Pamu D. Nanotheranostic Approach for the Management of Colorectal Cancer. NANOASIA. 2024;14(3) [Crossref]
22- Bernad S, Bunge A, Ioncica M, Turcu R, Dan M, Socoliuc V, Susan-Resiga D, Bernad E. Impact of the Different Molecular Weights of Polyethylene Glycol (PEG) Coating Agents on the Magnetic Targeting Characteristics of Functionalized Magnetoresponsive Nanoclusters. Magnetochemistry. 2024;10(7):51 [Crossref]